•
Jun 30, 2020

REGENXBIO Q2 2020 Earnings Report

Total Revenue
$16.6M
Previous year: $7.88M
+110.2%
EPS
-$0.91
Previous year: -$0.04
+2175.0%
Gross Profit
$11.9M
Previous year: $5.95M
+99.6%
Cash and Equivalents
$94.2M
Previous year: $55.1M
+70.9%
Free Cash Flow
-$24.8M
Previous year: -$29.3M
-15.5%
Total Assets
$450M
Previous year: $529M
-15.0%

REGENXBIO

REGENXBIO